Adam Andruska, MD, MSE, and Ke Yuan, PhD, will both receive the 2023 PHA Innovation Research Award. The grant award supports innovative PH research that introduces a new scientific or medical paradigm, challenges a current paradigm, examines an existing problem from a new perspective.
Adam Andruska, MD
Andruska is an instructor in the Department of Pulmonary, Allergy and Critical Care Medicine at Stanford University in Stanford, California. He is board certified in pulmonary medicine and completed his fellowship in pulmonary and critical care at Stanford University.
Andruska’s project, “T-Cell vascular signaling as a therapeutic target in PAH,” will explore the role of T-cells in the signaling pathways related to the blood vessels in the lungs. The project will also explore how T-cells affect the function and structure of blood vessels in the lungs, contributing to the development or progression of pulmonary arterial hypertension.
Ke Yuan, PhD
Yuan is an assistant professor of pediatrics at Harvard Medical School in Boston and an associate scientific researcher at Boston Children’s Hospital. Yuan obtained her medical degree at Temple University in Philadelphia, followed by a postdoctoral fellowship in pulmonary and critical care medicine at Stanford University. Yuan joined Boston Children’s Hospital in 2019 as an assistant professor.
Yuan’s project, “Perivascular cells contribute to flow-induced PH,” will explore behavior, function, or interaction of perivascular cells in response to altered blood flow patterns or conditions that lead to pulmonary hypertension. By understanding the role of these cells in flow-induced PH, researchers aim to identify potential mechanisms or targets that could be therapeutically manipulated to manage or treat this condition.
